The Olivia Newton-John Cancer Centre at Melbourne's Austin Hospital runs one of Australia's busiest phase 1 units for immunotherapies and antibody-drug conjugates; its research institute grew out of the Ludwig Institute's Melbourne branch and leads antibody PET, FAPI and PSMA imaging work.
The Olivia Newton-John Cancer Wellness and Research Centre opened at Austin Health in Heidelberg, Melbourne, in 2012, and the Olivia Newton-John Cancer Research Institute (a La Trobe University school of cancer medicine) grew out of the Melbourne branch of the Ludwig Institute for Cancer Research, which produced landmark tumour immunology and antibody work under Andrew Scott and Jonathan Cebon. The centre runs one of Australia's busiest phase 1 units for immunotherapies and antibody-drug conjugates, hosts a leading molecular imaging programme (antibody PET, FAPI and PSMA imaging), and combines cancer care with a wellness model that includes exercise and supportive therapies. Its investigators have led international trials in gastrointestinal cancers, melanoma and glioma.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-08.
Matched to Olivia Newton-John Cancer Wellness & Research Centre, including child institutions. 205 works · 2,449 citations · 77% open access · 12% clinical trials · 2% reviews.
Shares Immuno-PET, Melanoma, Immune checkpoint inhibitors.
Shares Exercise & lifestyle oncology, Melanoma, Immune checkpoint inhibitors.
Shares Exercise & lifestyle oncology, Gastric & gastro-oesophageal junction cancer.
Shares Exercise & lifestyle oncology, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
Shares Immuno-PET, Glioma & glioblastoma.
Shares Marco Herold, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/